RIGL
Rigel Pharmaceuticals Inc
NASDAQ: RIGL · HEALTHCARE · BIOTECHNOLOGY
$39.07
+1.48% today
Updated 2026-07-29
Market cap
$750.07M
P/E ratio
2.10
P/S ratio
2.50x
EPS (TTM)
$19.29
Dividend yield
—
52W range
$19 – $52
Volume
0.4M
Rigel Pharmaceuticals Inc (RIGL) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$39.07
12-Month target
$32.39
2030 Target
$54.79
Intrinsic (DCF)
$279.73
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.2B | $0.3B | $0.4B | $0.4B | $0.5B | $0.6B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 2.10x (capped 25x) · Margin: 121.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.